Healthcare provider profile · identity verified

Saida Hardoon, MD

Family Practice · BEAUMONT, CA · NPI 1174050611

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	436	182
Amlodipine Besylate	Amlodipine Besylate	344	138
Levothyroxine Sodium	Levothyroxine Sodium	302	124
Losartan Potassium	Losartan Potassium	279	121
Lisinopril	Lisinopril	223	95
Gabapentin	Gabapentin	202	83
Hydrochlorothiazide	Hydrochlorothiazide	199	83
Metformin Hcl	Metformin Hcl	162	73
Rosuvastatin Calcium	Rosuvastatin Calcium	156	67
Pantoprazole Sodium	Pantoprazole Sodium	155	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	133	37
Omeprazole	Omeprazole	130	55
Alendronate Sodium	Alendronate Sodium	116	40
Metoprolol Succinate	Metoprolol Succinate	111	44
Trazodone Hcl	Trazodone Hcl	109	36
Eliquis	Apixaban	103	33
Albuterol Sulfate Hfa	Albuterol Sulfate	96	49
Sertraline Hcl	Sertraline Hcl	93	30
Furosemide	Furosemide	84	37
Montelukast Sodium	Montelukast Sodium	83	28
Allopurinol	Allopurinol	75	29
Glipizide	Glipizide	74	26
Simvastatin	Simvastatin	71	31
Duloxetine Hcl	Duloxetine Hcl	68	31
Potassium Chloride	Potassium Chloride	65	28
Carvedilol	Carvedilol	63	28
Metoprolol Tartrate	Metoprolol Tartrate	61	30
Escitalopram Oxalate	Escitalopram Oxalate	59	22
Meloxicam	Meloxicam	58	22
Pravastatin Sodium	Pravastatin Sodium	58	23
Tamsulosin Hcl	Tamsulosin Hcl	56	25
Atenolol	Atenolol	53	21
Citalopram Hbr	Citalopram Hydrobromide	52	18
Tramadol Hcl	Tramadol Hcl	50	14
Famotidine	Famotidine	49	26
Ibuprofen	Ibuprofen	47	25
Jardiance	Empagliflozin	44	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	17
Metformin Hcl Er	Metformin Hcl	40	22
Fluticasone Propionate	Fluticasone Propionate	39	24
Benazepril Hcl	Benazepril Hcl	38	16
Pregabalin	Pregabalin	38	16
Ketoconazole	Ketoconazole	37	21
Nifedipine Er	Nifedipine	36	15
Clopidogrel	Clopidogrel Bisulfate	35	16
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Ozempic	Semaglutide	31	14
Lovastatin	Lovastatin	30	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	11
Synthroid	Levothyroxine Sodium	29	13
Triamcinolone Acetonide	Triamcinolone Acetonide	29	16
Alprazolam	Alprazolam	28	13
Hydralazine Hcl	Hydralazine Hcl	28	12
Clonidine Hcl	Clonidine Hcl	27	13
Baclofen	Baclofen	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	22
Donepezil Hcl	Donepezil Hcl	26	13
Oxybutynin Chloride Er	Oxybutynin Chloride	26	13
Valsartan	Valsartan	26	13
Januvia	Sitagliptin Phosphate	25	11
Buspirone Hcl	Buspirone Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Bupropion Xl	Bupropion Hcl	22	11
Valacyclovir	Valacyclovir Hcl	22	suppressed
Finasteride	Finasteride	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	11
Spironolactone	Spironolactone	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Cephalexin	Cephalexin	17	13
Estradiol	Estradiol	17	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nystatin	Nystatin	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Progesterone	Progesterone, Micronized	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Linzess	Linaclotide	14	suppressed
Naproxen	Naproxen	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Premarin	Estrogens, Conjugated	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error